Home › PeptiDream Announces Collaboration And License Agreement With Lilly To Discover Macrocyclic Peptide Drug Candidates
 

Keywords :   


PeptiDream Announces Collaboration And License Agreement With Lilly To Discover Macrocyclic Peptide Drug Candidates

2013-12-30 05:48:10| drugdiscoveryonline News Articles

PeptiDream Inc, a Tokyo-based biopharmaceutical company (PeptiDream), recenlty announced that they have entered into a Collaboration and License Agreement with US-based Eli Lilly and Company (Lilly) on 19 December 2013

Tags: agreement license drug discover

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
29.06Eastern North Pacific Tropical Weather Outlook
29.06Atlantic Tropical Weather Outlook
29.06Tropical Storm Beryl Graphics
29.06Tropical Storm Beryl Forecast Discussion Number 2
29.06Tropical Storm Beryl Public Advisory Number 2
29.06Summary for Tropical Storm Beryl (AT2/AL022024)
29.06Tropical Storm Beryl Wind Speed Probabilities Number 2
29.06Tropical Storm Beryl Forecast Advisory Number 2
More »